Shinzato Yukiko, Nakayama Yoshiro, Okamoto Shiki, Millman Jasmine F, Uema Tsugumi, Honma Ken-Ichiro, Tamaki Atsuko, Uehara Moriyuki, Teruya Taiki, Yabiku Takamitsu, Ishiki Yohei, Yonaha Ken, Arakaki Ko-Ichiro, Higa Moritake, Koizumi Hideki, Nakamura Koshi, Shimabukuro Michio, Masuzaki Hiroaki
Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Nakagami, Okinawa 903-0215 Japan.
Department of Ophthalmology, Tomishiro Central Hospital, 25 Ueda, Tomigusuku, Okinawa 901-0243 Japan.
Diabetol Int. 2024 May 5;15(3):535-543. doi: 10.1007/s13340-024-00724-7. eCollection 2024 Jul.
This cohort study investigated the association between treatment cessation and incidence/progression of diabetic retinopathy (DR) in Japanese patients with type 2 diabetes mellitus (T2DM).
Data were extracted from electronic medical records at the University of the Ryukyu Hospital and the Tomishiro Central Hospital of Okinawa, Japan. We enrolled 417 diabetic patients without DR ( = 281) and with nonproliferative DR ( = 136) at the baseline. Treatment cessation was defined as failing to attend outpatient clinics for at least twelve months prior to the baseline. After a median follow-up of 7 years, we compared the incidence/progression rate of DR including nonproliferative and proliferative DR between patients with and without treatment cessation and calculated the odds ratio (OR) in the treatment cessation group using a logistic regression model.
The overall prevalence of treatment cessation was 13% in patients with T2DM. Characteristics of treatment cessation included relative youth (57 ± 11 years vs. 63 ± 12 years, < 0.01). Treatment cessation was tightly associated with the incidence of DR (OR 4.20 [95% confidence interval [CI] 1.46-12.04, < 0.01) and also incidence/progression of DR (OR 2.70 [1.28-5.69], < 0.01), even after adjusting for age, sex, BMI, duration of T2DM, and HbA1c level.
By considering major confounding factors, the present study demonstrates an independent association between treatment cessation and incidence of DR in patients with T2DM, highlighting treatment cessation as an independent risk for DR in T2DM.
The online version contains supplementary material available at 10.1007/s13340-024-00724-7.
本队列研究调查了日本2型糖尿病(T2DM)患者治疗中断与糖尿病视网膜病变(DR)的发病率/进展之间的关联。
数据取自日本冲绳县琉球大学医院和泊江中央医院的电子病历。我们纳入了417例基线时无DR(n = 281)和非增殖性DR(n = 136)的糖尿病患者。治疗中断定义为在基线前至少十二个月未到门诊就诊。经过7年的中位随访后,我们比较了有和没有治疗中断的患者之间DR(包括非增殖性和增殖性DR)的发病率/进展率,并使用逻辑回归模型计算了治疗中断组的优势比(OR)。
T2DM患者中治疗中断的总体患病率为13%。治疗中断的特征包括相对年轻(57±11岁对63±12岁,P < 0.01)。即使在调整了年龄、性别、BMI、T2DM病程和糖化血红蛋白水平后,治疗中断仍与DR的发病率(OR 4.20 [95%置信区间[CI] 1.46 - 12.04,P < 0.01])以及DR的发病率/进展(OR 2.70 [1.28 - 5.69],P < 0.01)密切相关。
通过考虑主要混杂因素,本研究证明了T2DM患者治疗中断与DR发病率之间存在独立关联,突出了治疗中断是T2DM中DR的独立风险因素。
在线版本包含可在10.1007/s13340 - 024 - 00724 - 7获取的补充材料。